Lv1
50 积分 2024-07-05 加入
Overcoming therapy resistance in EGFR-mutant lung cancer
9小时前
已完结
Overcoming tyrosine kinase inhibitor resistance in lung cancer brain metastasis with CTLA4 blockade
1个月前
已完结
Cancer of Unknown Primary
1个月前
已关闭
Cancer of Unknown Primary
1个月前
已关闭
EGFR Mutations and Lung Cancer
1个月前
已完结
Immune heterogeneity in small-cell lung cancer and vulnerability to immune checkpoint blockade
2个月前
已完结
Efficacy and safety of re-challenging 160 mg furmonertinib for advanced NSCLC after resistance to third-generation EGFR-TKIs targeted agents: A real-world study
2个月前
已完结
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
2个月前
已完结
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
3个月前
已完结
Targeting METTL3 reprograms the tumor microenvironment to improve cancer immunotherapy
3个月前
已完结
皖公网安备34019202002308
